Technical comment on: Rachamin et al. Statin treatment and LDL target value achievement in Swiss general practice – a retrospective observational study

Michel Romanens; Edward A. Schober; Ansgar Adams; Sandor Balint; Walter Warmuth

doi:10.4414/smw.2020.20373

Technical comment

Vol. 150 No. 4748 (2020)

Technical comment on: Rachamin et al. Statin treatment and LDL target value achievement in Swiss general practice – a retrospective observational study

Michel Romanens⁺⁻
Edward A. Schober⁺⁻
Ansgar Adams⁺⁻
Sandor Balint⁺⁻
Walter Warmuth⁺⁻

DOI: https://doi.org/10.4414/smw.2020.20373
Cite this as:: Swiss Med Wkly. 2020;150:w20373
Published: 23.11.2020

References

Rachamin Y, Meier R, Rosemann T, Langenegger S, Markun S. Statin treatment and LDL target value achievement in Swiss general practice - a retrospective observational study. Swiss Med Wkly. 2020;150(2122):w20244. doi:.https://doi.org/10.4414/smw.2020.20244
Mach F, Baigent C, Catapano AL, Koskinas KC, Casula M, Badimon L, et al.; ESC Scientific Document Group. 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. Eur Heart J. 2020;41(1):111–88. doi:.https://doi.org/10.1093/eurheartj/ehz455
Conroy RM, Pyörälä K, Fitzgerald AP, Sans S, Menotti A, De Backer G, et al.; SCORE project group. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J. 2003;24(11):987–1003. doi:.https://doi.org/10.1016/S0195-668X(03)00114-3
Romanens M, Szucs T, Sudano I, Adams A. Agreement of PROCAM and SCORE to assess cardiovascular risk in two different low risk European populations. Prev Med Rep. 2019;13:113–7. doi:.https://doi.org/10.1016/j.pmedr.2018.11.019
Romanens M, Sudano I, Szucs T, Adams A. Medical costs per QALY of statins based on Swiss Medical Board assumptions. Cardiovasc Med. 2017;17(4):96–100. doi:.https://doi.org/10.4414/cvm.2017.0047
Felder S, Jüni P, Meier CA, et al. SMB Statin Recommendation [Internet]. 2014. Available from: https://www.swissmedicalboard.ch/fileadmin/public/news/2013/bericht_smb_statine_primaerpraevention_lang_2013.pdf

How to Cite

1.

Romanens M, Schober EA, Adams A, Balint S, Warmuth W. Technical comment on: Rachamin et al. Statin treatment and LDL target value achievement in Swiss general practice – a retrospective observational study. Swiss Med Wkly [Internet]. 2020 Nov. 23 [cited 2024 Apr. 23];150(4748):w20373. Available from: https://smw.ch/index.php/smw/article/view/2905

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

Most read articles by the same author(s)

Michel Romanens, Isabella Sudano, Ansgar Adams, Edward A. Schober, Sonographic assessment of carotid atherosclerosis: preferred risk indicator for future cardiovascular events? , Swiss Medical Weekly: Vol. 149 No. 5152 (2019)
Michel Romanens, Ansgar Adams, Waldemar Bojara, Sandor Balint, Walter Warmuth, Cost-effectiveness analysis of statins in primary care: results from the Arteris cohort study , Swiss Medical Weekly: Vol. 151 No. 1516 (2021)
Michel Romanens, Isabella Sudano, Ansgar Adams, Walter Warmuth, Advanced carotid atherosclerosis in middle-aged subjects: comparison with PROCAM and SCORE risk categories, the potential for reclassification and cost-efficiency of carotid ultrasound in the setting of primary care , Swiss Medical Weekly: Vol. 149 No. 2930 (2019)
Michel Romanens, Ansgar Adams, Walter Warmuth, PROCAM based myocardial infarction risk in relation to global vascular disease risk: observations from the ARCO cohort study , Swiss Medical Weekly: Vol. 152 No. 0708 (2022)
Michel Romanens, Franz Ackermann, Isabella Sudano, Thomas Szucs, J. David Spence, Arterial age as a substitute for chronological age in the AGLA risk function could improve coronary risk prediction , Swiss Medical Weekly: Vol. 144 No. 2728 (2014)
Michel Romanens, Clarification of check-up recommendations in adults , Swiss Medical Weekly: Vol. 145 No. 2728 (2015)
Michel Romanens, Ansgar Adams, Michel Wenger, Walter Warmuth, Isabella Sudano, Prognostic impact of carotid plaque imaging using total plaque area added to SCORE2 in middle-aged subjects: the ARteris Cardiovascular Outcome (ARCO) cohort study , Swiss Medical Weekly: Vol. 154 No. 1 (2024)
Michel Romanens, Technical comment on: Güller et al. Lower hospital volume is associated with higher mortality after oesophageal, gastric, pancreatic and rectal cancer resection , Swiss Medical Weekly: Vol. 148 No. 0102 (2018)

[1] Rachamin Y, Meier R, Rosemann T, Langenegger S, Markun S. Statin treatment and LDL target value achievement in Swiss general practice - a retrospective observational study. Swiss Med Wkly. 2020;150(2122):w20244. doi:.https://doi.org/10.4414/smw.2020.20244

[2] Mach F, Baigent C, Catapano AL, Koskinas KC, Casula M, Badimon L, et al.; ESC Scientific Document Group. 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. Eur Heart J. 2020;41(1):111–88. doi:.https://doi.org/10.1093/eurheartj/ehz455

[3] Conroy RM, Pyörälä K, Fitzgerald AP, Sans S, Menotti A, De Backer G, et al.; SCORE project group. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J. 2003;24(11):987–1003. doi:.https://doi.org/10.1016/S0195-668X(03)00114-3

[4] Romanens M, Szucs T, Sudano I, Adams A. Agreement of PROCAM and SCORE to assess cardiovascular risk in two different low risk European populations. Prev Med Rep. 2019;13:113–7. doi:.https://doi.org/10.1016/j.pmedr.2018.11.019

[5] Romanens M, Sudano I, Szucs T, Adams A. Medical costs per QALY of statins based on Swiss Medical Board assumptions. Cardiovasc Med. 2017;17(4):96–100. doi:.https://doi.org/10.4414/cvm.2017.0047

[6] Felder S, Jüni P, Meier CA, et al. SMB Statin Recommendation [Internet]. 2014. Available from: https://www.swissmedicalboard.ch/fileadmin/public/news/2013/bericht_smb_statine_primaerpraevention_lang_2013.pdf